Market revenue in 2023 | USD 209.5 million |
Market revenue in 2030 | USD 424.3 million |
Growth rate | 10.6% (CAGR from 2023 to 2030) |
Largest segment | Functional genomics |
Fastest growing segment | Pathway Analysis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery |
Key market players worldwide | Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Eppendorf, Eurofins Scientific SE, Roche Holding AG ADR, GE Aerospace, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc, Qiagen NV, Quest Diagnostics Inc, Thermo Fisher Scientific Inc, 23andMe Holding Co Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genomics market will help companies and investors design strategic landscapes.
Functional genomics was the largest segment with a revenue share of 31.55% in 2023. Horizon Databook has segmented the Denmark genomics market based on functional genomics, epigenomics, pathway analysis, biomarker discovery covering the revenue growth of each sub-segment from 2018 to 2030.
Denmark has a Danish National Genome Center that enables genetic testing of at least 60,000 patients as part of providing more personalized treatment. The Danish initiative aims to deliver personalized medicine and genetic analyses directly to patients and provide precise diagnosis and treatment.
Young people and children with rare diseases are the first to benefit from the Danish genome center. In April 2022, the Danish National Genome Center entered into a partnership with Lifebit, which aims at delivering personalized medicine in the country.
Furthermore, increasing usage of Direct-to-Consumer Genetic Testing (DTC-GT) is expected to create growth opportunities for the market growth. Commercial genetic testing is increasingly used where people can buy a genetic test online without the involvement of healthcare professionals.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark genomics market , including forecasts for subscribers. This country databook contains high-level insights into Denmark genomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account